SOURCE: Edwards Lifesciences

Edwards Lifesciences

August 12, 2013 17:06 ET

Edwards Lifesciences to Present at the Canaccord Genuity Growth Conference

IRVINE, CA--(Marketwired - Aug 12, 2013) - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the Canaccord Genuity Growth Conference 2013 on Wednesday, August 14, 2013. Thomas M. Abate, Edwards' corporate vice president and chief financial officer, is scheduled to speak to attendees at the InterContinental Boston at 2:30 p.m. EDT.

A live webcast will be available to all interested parties on the Edwards Lifesciences investor relations website at http://ir.edwards.com. Following the presentation, an archived version of the webcast will be available on the Edwards investor relations website in the News and Events section and via the Edwards Lifesciences Investor Relations App for mobile devices.

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.

Contact Information

  • Media Contact:
    Sarah Huoh
    949-250-5070

    Investor Contact:
    David K. Erickson
    949-250-6826

    Edwards Lifesciences Corporation
    One Edwards Way
    Irvine, CA USA 92614
    Phone: 949.250.2500
    Fax: 949.250.2525
    www.edwards.com